Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nezam H Afdhal

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Journal of Gastroenterology and Hepatology|March 18, 2015
Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapyEdoardo G Giannini, Nezam H Afdhal, Samuel H Sigal, et al.
Gastroenterology|March 15, 2018
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus InfectionOmar El-Sherif, Z Gordon Jiang, Elliot B Tapper, et al.
Journal of Hepatology|February 24, 2007
Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis CGamal Esmat, Mohamed Metwally, Khalid R Zalata, et al.
Hepatology Communications|April 21, 2022
First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamideCalvin Q Pan, Nezam H Afdhal, Victor Ankoma-Sey, et al.
Hepatology (Baltimore, Md.)|November 27, 2004
Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapyPaul J Pockros, Mitchell L Shiffman, Eugene R Schiff, et al.
Hepatology (Baltimore, Md.)|October 12, 2007
Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virusJohn G McHutchison, Bruce R Bacon, Stuart C Gordon, et al.
Hepatology International|March 20, 2015
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 yearsMaria Buti, Scott Fung, Edward Gane, et al.
Journal of Clinical Pharmacology|October 21, 2009
Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis CRoy L Hawke, Sarah J Schrieber, Tedi A Soule, et al.
Hepatology (Baltimore, Md.)|July 3, 2021
Genetic Variation in the Mitochondrial Glycerol-3-Phosphate Acyltransferase Is Associated With Liver InjuryAaron Hakim, Matthew Moll, Joseph Brancale, et al.
Hepatology (Baltimore, Md.)|September 12, 2017
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trialRohit Loomba, Eric Lawitz, Parvez S Mantry, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Journal of Gastroenterology and Hepatology|March 18, 2015
Non-cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapyEdoardo G Giannini, Nezam H Afdhal, Samuel H Sigal, et al.
Gastroenterology|March 15, 2018
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus InfectionOmar El-Sherif, Z Gordon Jiang, Elliot B Tapper, et al.
Journal of Hepatology|February 24, 2007
Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis CGamal Esmat, Mohamed Metwally, Khalid R Zalata, et al.
Hepatology Communications|April 21, 2022
First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamideCalvin Q Pan, Nezam H Afdhal, Victor Ankoma-Sey, et al.
Hepatology (Baltimore, Md.)|November 27, 2004
Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapyPaul J Pockros, Mitchell L Shiffman, Eugene R Schiff, et al.
Hepatology (Baltimore, Md.)|October 12, 2007
Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virusJohn G McHutchison, Bruce R Bacon, Stuart C Gordon, et al.
Hepatology International|March 20, 2015
Long-term clinical outcomes in cirrhotic chronic hepatitis B patients treated with tenofovir disoproxil fumarate for up to 5 yearsMaria Buti, Scott Fung, Edward Gane, et al.
Journal of Clinical Pharmacology|October 21, 2009
Silymarin ascending multiple oral dosing phase I study in noncirrhotic patients with chronic hepatitis CRoy L Hawke, Sarah J Schrieber, Tedi A Soule, et al.
Hepatology (Baltimore, Md.)|July 3, 2021
Genetic Variation in the Mitochondrial Glycerol-3-Phosphate Acyltransferase Is Associated With Liver InjuryAaron Hakim, Matthew Moll, Joseph Brancale, et al.
Hepatology (Baltimore, Md.)|September 12, 2017
The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trialRohit Loomba, Eric Lawitz, Parvez S Mantry, et al.
Pageof 12